IL110024A0 - Protein drugs delivery system - Google Patents

Protein drugs delivery system

Info

Publication number
IL110024A0
IL110024A0 IL11002494A IL11002494A IL110024A0 IL 110024 A0 IL110024 A0 IL 110024A0 IL 11002494 A IL11002494 A IL 11002494A IL 11002494 A IL11002494 A IL 11002494A IL 110024 A0 IL110024 A0 IL 110024A0
Authority
IL
Israel
Prior art keywords
delivery system
protein drugs
drugs delivery
protein
drugs
Prior art date
Application number
IL11002494A
Other versions
IL110024A (en
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Priority to IL110024A priority Critical patent/IL110024A/en
Publication of IL110024A0 publication Critical patent/IL110024A0/en
Priority to AU28270/95A priority patent/AU2827095A/en
Priority to US08/750,674 priority patent/US6692766B1/en
Priority to PCT/US1995/007519 priority patent/WO1995034294A1/en
Publication of IL110024A publication Critical patent/IL110024A/en
Priority to US10/630,918 priority patent/US20040185107A1/en
Priority to US10/630,917 priority patent/US7189414B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL110024A 1994-06-15 1994-06-15 Controlled release oral drug delivery system containing hydrogel- forming polymer IL110024A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IL110024A IL110024A (en) 1994-06-15 1994-06-15 Controlled release oral drug delivery system containing hydrogel- forming polymer
AU28270/95A AU2827095A (en) 1994-06-15 1995-06-13 Controlled release oral drug delivery system
US08/750,674 US6692766B1 (en) 1994-06-15 1995-06-13 Controlled release oral drug delivery system
PCT/US1995/007519 WO1995034294A1 (en) 1994-06-15 1995-06-13 Controlled release oral drug delivery system
US10/630,918 US20040185107A1 (en) 1994-06-15 2003-07-31 Controlled release oral drug delivery system
US10/630,917 US7189414B2 (en) 1994-06-15 2003-07-31 Controlled release oral drug delivery system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL110024A IL110024A (en) 1994-06-15 1994-06-15 Controlled release oral drug delivery system containing hydrogel- forming polymer

Publications (2)

Publication Number Publication Date
IL110024A0 true IL110024A0 (en) 1994-10-07
IL110024A IL110024A (en) 1998-04-05

Family

ID=11066240

Family Applications (1)

Application Number Title Priority Date Filing Date
IL110024A IL110024A (en) 1994-06-15 1994-06-15 Controlled release oral drug delivery system containing hydrogel- forming polymer

Country Status (3)

Country Link
AU (1) AU2827095A (en)
IL (1) IL110024A (en)
WO (1) WO1995034294A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1086064A2 (en) * 1998-06-10 2001-03-28 Glycodesign Inc. Directed combinatorial compound library and high throughput assays for screening same
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
EP1390383B1 (en) 2001-05-11 2012-02-29 Isis Pharmaceuticals, Inc. Antisense permeation enhancers
ES2300568T3 (en) 2002-03-20 2008-06-16 Mannkind Corporation INHALATION APPARATUS
US7279457B2 (en) 2004-03-12 2007-10-09 Biodel, Inc. Rapid acting drug delivery compositions
US20080090753A1 (en) 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
CA2575692C (en) 2004-08-20 2014-10-14 Mannkind Corporation Catalysis of diketopiperazine synthesis
BR122019022692B1 (en) 2004-08-23 2023-01-10 Mannkind Corporation THERAPEUTIC DRY POWDER COMPOSITION CONTAINING DICETOPIPERAZINE, AT LEAST ONE TYPE OF CATION AND ONE BIOLOGICALLY ACTIVE AGENT
HUE028691T2 (en) 2005-09-14 2016-12-28 Mannkind Corp Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
EP1986679B1 (en) 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US7704977B2 (en) 2006-04-07 2010-04-27 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
WO2009137078A1 (en) 2008-05-07 2009-11-12 Merrion Research Iii Limited Compositions of peptides and processes of preparation thereof
AR072114A1 (en) 2008-06-13 2010-08-04 Mannkind Corp A DRY POWDER INHALER AND DRUG SUPPLY SYSTEM
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
BRPI0914308B8 (en) 2008-06-20 2021-06-22 Mannkind Corp inhalation system
ES2344673B1 (en) * 2008-08-07 2011-05-03 Italfarmaco, S.A. USE OF ESTRIOL IN THE PREPARATION OF A PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF VAGINAL ATROPHY IN WOMEN WITH RISK OF POTOLOGIATUMORAL.
TWI614024B (en) 2008-08-11 2018-02-11 曼凱公司 Use of ultrarapid acting insulin
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
CA2754595C (en) 2009-03-11 2017-06-27 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
KR101875969B1 (en) 2009-06-12 2018-07-06 맨카인드 코포레이션 Diketopiperazine microparticles with defined specific surface areas
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
EP2579844B1 (en) 2010-06-10 2016-02-24 Midatech Ltd. Nanoparticle film delivery systems
RU2571331C1 (en) 2010-06-21 2015-12-20 Маннкайнд Корпорейшн Systems and methods for dry powder drug delivery
KR20140026354A (en) 2011-01-07 2014-03-05 메리온 리서치 Ⅲ 리미티드 Pharmaceutical compositions of iron for oral administration
JP6133270B2 (en) 2011-04-01 2017-05-24 マンカインド コーポレイション Blister packaging for drug cartridge
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
JP6018640B2 (en) 2011-10-24 2016-11-02 マンカインド コーポレイション Analgesic composition effective for alleviating pain, and dry powder and dry powder drug delivery system comprising the composition
SG11201500218VA (en) 2012-07-12 2015-03-30 Mannkind Corp Dry powder drug delivery systems and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
WO2014144895A1 (en) 2013-03-15 2014-09-18 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
AU2014290438B2 (en) 2013-07-18 2019-11-07 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
WO2015021064A1 (en) 2013-08-05 2015-02-12 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
JP7211704B2 (en) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス A tablet containing a GLP-1 agonist and an enteric coating

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD252539A1 (en) * 1986-09-17 1987-12-23 Berlin Chemie Veb METHOD FOR ORAL APPLICATION OF BIOLOGICALLY ACTIVE PEPTIDES WITH DELAYED EFFECT
JPH07138182A (en) * 1993-11-12 1995-05-30 Toyobo Co Ltd Sustained release type pharmaceutical preparation applicable to mucous membrane of oral cavity

Also Published As

Publication number Publication date
AU2827095A (en) 1996-01-05
WO1995034294A1 (en) 1995-12-21
IL110024A (en) 1998-04-05

Similar Documents

Publication Publication Date Title
IL110024A0 (en) Protein drugs delivery system
GB2338414B (en) Intravesical drug delivery system
AU4505496A (en) Sustained-release drug delivery system
IL113459A0 (en) Electrophoretic cuff drug delivery system
SG80049A1 (en) Delivery system
AU3204995A (en) Closed drug delivery system
EP0774955A4 (en) Improved bioadhesive pharmaceutical delivery system
IL125042A (en) Gastrointestinal drug delivery system
EP1061987A4 (en) Drug delivery system
EP0989878A4 (en) Drug delivery system
AU3154895A (en) Tastemasked liquid pharmaceutical delivery system
AU7201998A (en) Drug delivery system
EP1013269A4 (en) Improvement in medicament administration system
EP1021137A4 (en) Drug delivery system
GB9721367D0 (en) Delivery system
EP0913159A4 (en) Drug delivery system using galactoxyloglucan
GB9325330D0 (en) Fluorocyclodextrin drug delivery system
GB9404293D0 (en) Drug delivery system
EP1011508A4 (en) Constituent delivery system
GB2292887B (en) Drug delivery system
GB9617607D0 (en) Infusate delivery system
IL106070A0 (en) Protein drugs delivery system
GB9600471D0 (en) Drug delivery system
GB9614501D0 (en) Drug delivery system
GB9524961D0 (en) Drug delivery system

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees